Michael J. Campa

Tumor infiltrating Foxp3⁺ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

Rebecca P. Petersen, Michael J. Campa, Justin Sperlazza et al. · Cancer · 2006 · 435 citations · Full text

Life Sciences, Immunology, Oncology +17

Panel of Serum Biomarkers for the Diagnosis of Lung Cancer

Edward F. Patz, Michael J. Campa, Elizabeth B. Gottlin et al. · Journal of Clinical Oncology · 2007 · 249 citations · Full text

Medicine, Biochemistry, Oncology +17

Autocrine Complement Inhibits IL10-Dependent T-cell–Mediated Antitumor Immunity to Promote Tumor Progression

Yu Wang, Shengnan Sun, Qing Liu et al. · Cancer Discovery · 2016 · 164 citations · Full text

Life Sciences, Immunology, Oncology +17

Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.

Michael J. Campa, Michael Z. Wang, Brandon A. Howard et al. · PubMed · 2003 · 156 citations

Medicine, Molecular Biology, Oncology +17

Identification and validation of a potential lung cancer serum biomarker detected by matrix‐assisted laser desorption/ionization‐time of flight spectra analysis

Brandon A. Howard, Michael Z. Wang, Michael J. Campa et al. · PROTEOMICS · 2003 · 122 citations · Full text

Pharmacy, Biochemistry, Oncology +17